StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
CARERATING.NS$1639.20+2.39%
Fair $1639.20+0.0%

CARERATING.NS

CARE Ratings Limited

Financial Services / Financial Data & Stock ExchangesNSE

$1639.20

+38.30 (+2.39%)

Fairly Valued+0.0%Fair Value $1639.20Fund rank 38/100 · Data gapFallback financials|
SA 51/C
F-Score: 6/9

Book/ROE base 3Y

n/d

n/d CAGR · P/B n/d

Book/ROE base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 100% · confianza 20%

Book/ROE escenarios

weak_data · book/share n/d · quality 62.0/100

Data gap 38/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 88/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

51/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); financial Book/ROE targets are disabled until manually verified.
Thesis & Journal · CARERATING.NSLocal privado en este navegador · CARE Ratings Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$49.3B

P/E

28.8x

↑

EV/EBITDA

19.5x

↑

ROE

18.4%

↑

Gross Margin

54.6%

↑

Debt/Equity

0.03

↓
52-Week Range$1639
$1393$1964

TradingView lightweight chart

CARERATING.NS price, volumen y niveles de valoración

Último $1,639Periodo +77.7%
Fair value: $1,639

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+19.2%

FCF CAGR

+25.3%

FCF margin

29.4%

FCF / Net income

0.81x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $4.73B · net income $1.71B · FCF $1.39B

2023-FY → 2026-FY

Gross margin

54.6%-0.9% pts

Operating margin

38.7%+4.8% pts

Net margin

36.2%+6.2% pts

FCF margin

29.4%+4.1% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$4.73B$4.73B$4.02B$3.32B$2.79B
Net Income$1.71B$1.71B$1.37B$1.01B$835.3M
EBITDA$2.52B$2.52B$2.06B$1.59B$1.37B
EPS——45.6933.6728.17
Gross Margin54.6%54.6%53.0%54.8%55.5%
Operating Margin38.7%38.7%35.7%31.0%33.9%
Net Margin36.2%36.2%34.1%30.3%29.9%
Balance Sheet
Debt/Equity0.030.030.030.030.03
Current Ratio5.755.75———
Cash Flow
Free Cash Flow$1.39B$1.39B$1.08B$817.1M$707.4M
Returns
ROE18.4%18.4%17.0%14.0%12.4%
Valuation
P/E28.8428.8424.9534.2522.96
EV/EBITDA19.4619.4616.4921.5613.74
P/B5.285.284.254.802.85
Growth & Yield
Revenue Growth17.6%17.6%21.3%18.9%—
EPS Growth——35.7%19.5%—
Dividend Yield1.4%1.4%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total -0.3%

Total return

-0.3%

Start / end P/E

n/dx → n/dx

EPS bridge

45.69 → n/d

Residual

-1.7%

EPS growthn/d
Multiple reratingn/d
Dividend+1.4%
Residual / FX / buybacks / cross-term-1.7%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.